S. Tarık TEZCAN

· Allergy and Dermatology Rx products (Bilaxten, Zostex and Fastjel).

· Responsible for casualty assessment.

· Responsible for 3 Rx products, one of which has been the market leader in anhtihistamines in Turkiye for the past 3 years (Bilaxten).

• Worked in coordination with the Marketing Department in developing marketing strategy, producing materials for our field force and updating marketing materials as new medical data emerged such as clinical trials and guidelines.
• Ensured compliance with regulatory requirements by staying informed about changes in the industry and adjusting policies accordingly.
• Maintained and progressed KOL and HCP relations in the fields of Dermatology, ENT, Emergency Medicine, Family Medicine, Orthopedics and Physiotherapy.
• Performed over 250 (approximately 7-8 a month) Medical Manager presentations in leading clinics and hospitals.
• Attended over 20 medical congresses both locally and internationally.
• Directed staff training sessions on relevant topics such as new treatment protocols or regulatory updates to ensure consistent application of best practices throughout the organization''s medical management efforts.
• Directly involved in 4 periods of recruiting and training pharmaceutical representatives in which I have given the basic medical education, product education and training over 50 pharmaceutical representatives.
• Worked closely with the medical and marketing teams in 2 special projects involving my products of responsibility in Menarini Corporate-ITALY.
• Regularly scanned literatures and relevant medical information of the products under my responsibility as well as the relevant therapeutic areas.
• Personally assessed over 10 new products in their efficacy and safety as well as their competitions in the Turkish market, the relevant guidelines and therapeutic fileds as well as worked closely with the Regulatory and Marketing derpatments in creating final reports in their suitability for our compan
• Maintained up-to-date knowledge of industry trends and advancements in medical technology to inform evidence-based practice decisions within the organization.
• Directly responsible for the “Casualty Assessment” process.